SomnoMed Limited (SOM.AX)
Makes custom mouth devices to treat sleep apnea and teeth grinding.
0.47+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-43.7%
The outlook
SomnoMed is trading near the lower end of its 52-week range, well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst sentiment leans bearish overall, though the average price target sits roughly 118% above the current price, suggesting a significant gap between where the stock trades now and where analysts see potential value.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Price targetAvg target +118% vs current price
Analyst price target
~12-month · 3 analysts1.03average target+118.4% vs now
Now 0.47
Low 0.99High 1.09
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$103.3M
52-wk high
0.95
52-wk low
0.42
50-day avg
0.53
200-day avg
0.66
Trailing P/E
—